More...Summary
Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.
This report describes the development of the industry by upstream & downstream, industry overa
Table of Content
Part 1 Industry Overview
1.1 Glucagon Like Peptide-1 (GLP-1) Agonists Industry
1.1.1 Definition
1.1.2 Industry Trend
1.2 Industry Chain
1.2.1 Upstream
1.2.2 Technology
1.2.3 Cost Structure
1.2.4 Consumer Preference
1.2.2 Downstream
Part 2 Industry Overall
2.1 Industry History
2.2 Development Prospect
2.3 C